1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma Treatment Candidates into In Vivo Testing in Less Than One Year February 25, 2020 Press Release The partnership combines shared drug discovery expertise with integrated AI to identify promising targets in half the time of traditional R&D approaches. READ MORE
